4.2 Article

Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days

Journal

JOURNAL OF IMMUNOTOXICOLOGY
Volume 15, Issue 1, Pages 41-52

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/1547691X.2018.1445145

Keywords

Perfluoro-n-decanoic acid (PFDA); poly-; perfluoroalkyl substance (PFAS); hepatotoxicity

Categories

Funding

  1. NIH, National Institute of Environmental Health Sciences, NTP [N01-ES-55538]
  2. NTP Statistical Support [HHSN27320160001C]
  3. NTP Chemistry Support Services [N01-ES-55551]
  4. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103316] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Poly- and perfluoroalkyl substances (PFAS) are chemically and thermally stable, hydrophobic, lipophobic compounds used in stain repellants and water and oil surfactants, and associated with immunosuppression and peroxisome proliferator activity. Perfluoro-n-decanoic acid (PFDA, (CF3(CF2)(8)COOH), a fluorinated straight chain fatty acid compound, is reported to induce thymic atrophy and reversible bone marrow hypocellularity in rodent models. The objective of this study was to assess potential immunotoxicity of PFDA, due to its structural similarity to other immunosuppressive PFASs. Female Harlan Sprague-Dawley rats were exposed to 0-2.0mg PFDA/kg by oral gavage daily for 28d. Female B6C3F1/N mice were exposed once/week to 0-5.0mg PFDA/kg by gavage for 4weeks. Animals were evaluated for effects on immune cell populations in spleen and bone marrow, and innate, humoral-, and cell-mediated immunity. Mice were also evaluated for resistance to Influenza virus. Treatment-related hepatocyte necrosis and hepatomegaly were observed in rats treated with 0.5mg PFDA/kg/d. In mice, hepatomegaly (26-89%) was observed following exposure to 0.625mg PFDA/kg/week, while splenic atrophy (20%) was observed at 5.0mg PFDA/kg/week. At 5.0mg PFDA/kg/week, total spleen cells, and Ig+and NK+cells were decreased (17.6-27%). At 1.25mg PFDA/kg/week the numbers of splenic CD3(+), CD4(+), CD8(+), and Mac3(+) cells were decreased (10.5-39%). No changes were observed in leukocyte subpopulations in PFDA-exposed rats. Phagocytosis by fixed-tissue macrophages was decreased in liver (specific activity, 24-39%) at 0.25mg PFDA/kg/d in rats. PFDA-induced effects on humoral- and cell-mediated immunity, host resistance, and bone marrow progenitor cells were limited. These data suggest that exposure to PFDA may induce adverse effects in rat liver in a manner consistent with the PFAS class, and may also alter the balance of immune cell populations in lymphoid tissues in mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available